<http://webisa.webdatacommons.org/328060157>	<http://www.w3.org/ns/prov#value>	"going to need the full-on cooperation of pharmaceutical companies manufacturing drugs for other diseases that show potential for people living with HIV. The ACTG is interested in studying telmisartan to better understand the causes and treatment of non-AIDS complications associated with inflammation, such as cardiovascular disease, diabetes and cancers." .
<http://webisa.webdatacommons.org/328060157>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<poz.com> .
<http://webisa.webdatacommons.org/328060157>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .
<http://webisa.webdatacommons.org/prov/512436461>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/328060157> .